| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/1994 | CA2101817A1 Pradimicin compounds |
| 02/15/1994 | CA2101417A1 Prophylactic and therapeutic treatment of alzheimer's disease |
| 02/15/1994 | CA1327051C Enhancing drug delivery to the brain |
| 02/15/1994 | CA1327050C Phenolic thioethers, sulfoxides, and disulfides as inhibitors of 5-lipoxygenase |
| 02/15/1994 | CA1327047C Complexes of tellurium and selenium derivatives |
| 02/15/1994 | CA1327046C Tellurium and selenium compounds for the induction of in vivo and in vitro production of cytokines |
| 02/15/1994 | CA1327039C Ammine-alicyclic amine-platinum complexes and antitumor agents |
| 02/15/1994 | CA1327038C Anticancer compounds |
| 02/15/1994 | CA1327037C Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
| 02/15/1994 | CA1327013C Cosmetic composition |
| 02/15/1994 | CA1327011C Pharmaceutical compositions for piperidino alkanol-ibuprofen combination |
| 02/15/1994 | CA1327010C Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
| 02/15/1994 | CA1327009C Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative |
| 02/15/1994 | CA1327008C Anti-psychotic imidazobenzodiazepine |
| 02/15/1994 | CA1327007C Captopril and diltiazem composition and the like |
| 02/15/1994 | CA1327006C Process for preparing a retard product containing diltiazem for a single daily administration |
| 02/15/1994 | CA1327005C2 Therapeutic nucleosides |
| 02/15/1994 | CA1327004C Stabilized pharmaceutical composition and method of producing same |
| 02/15/1994 | CA1327003C Pharmacological use of uridine in the treatment of nervous disorders |
| 02/15/1994 | CA1327002C Elaboration of host defense mediators into biological fluids by systemic dsrna treatment |
| 02/15/1994 | CA1327001C Topically active compositions of double-stranded rnas |
| 02/15/1994 | CA1327000C Antiviral therapy for hepatitis b |
| 02/15/1994 | CA1326999C Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function |
| 02/15/1994 | CA1326998C Veterinary treatment |
| 02/15/1994 | CA1326994C Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 02/13/1994 | CA2103600A1 Isobutyl-substituted methanesulphonyl- quinolyl-methoxyphenyl-cycloalkylacetamides |
| 02/12/1994 | CA2103601A1 1,4-benzodioxane derivatives |
| 02/12/1994 | CA2103521A1 Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives |
| 02/12/1994 | CA2101998A1 Piperidino-3,4-dihydrocarbostyril compounds |
| 02/12/1994 | CA2100692A1 Pharmaceutical compositions containing esters of w-3 polyunsatured acids and their use in the topical treatment of morbid affections |
| 02/10/1994 | DE4226279A1 Liponucleotide von Seco-Nucleosiden, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel Liponucleotide Seco-nucleosides, their preparation and their use as antiviral drugs |
| 02/10/1994 | DE4226217A1 Treatment of "dry nose" using a surfactant - opt. combined with preservatives and/or bactericides and fungicides in physiological saline, to regulate the moisture content of nose and throat |
| 02/10/1994 | DE4226109A1 Use of high doses of acetyl salicylic acid - to inhibit the proliferation of smooth muscle cells by inhibiting migration from the media to the intima after vascular injury |
| 02/10/1994 | DE4225697A1 Topical pharmaceutical and cosmetic compsns. esp. for acne treatment |
| 02/10/1994 | DE4225569A1 Neue Sonde zur Tumordiagnostik oder Tumortherapie New probe for tumor diagnosis and tumor therapy |
| 02/09/1994 | EP0582515A1 Monohydrate of the disodium salt of 4-chlorophenylthiomethylene-bisphosphonic acid, its preparation and pharmaceutical compositions containing it |
| 02/09/1994 | EP0582506A1 Tetrahydronaphtalene derivatives, their preparation and their application in therapy |
| 02/09/1994 | EP0582502A1 Transdermal composition containing alfuzosin |
| 02/09/1994 | EP0582458A1 Compositions for the topical administration of spironolactone |
| 02/09/1994 | EP0582455A1 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 02/09/1994 | EP0582396A1 Taste-masking composition of bitter pharmaceutical agents |
| 02/09/1994 | EP0582368A1 Thienobenzodiazepine derivatives for treatment of CNS disorders |
| 02/09/1994 | EP0582338A2 17-Spiromethylene steroids |
| 02/09/1994 | EP0582330A1 Use of polysaccharides for treating acute peripheral neuropathies |
| 02/09/1994 | EP0582321A1 Combination of dipivalylepinephrine with a beta-blocker for diminishing the intraocular pressure |
| 02/09/1994 | EP0582318A1 Use of carnosic acid for its anticarcinogenic and antiviral properties |
| 02/09/1994 | EP0582261A1 Cephalosporin compounds and processes for the preparation thereof |
| 02/09/1994 | EP0582246A2 Mixture of polyglycerine fatty acids esters |
| 02/09/1994 | EP0582239A1 Pharmaceutical and/or cosmetic preparation and the use of such a preparation |
| 02/09/1994 | EP0582186A1 Process for producing solid pharmaceutical dosage forms with an extended two-stage release |
| 02/09/1994 | EP0582182A1 1-Aminoacetamidopyrroles and 1-amino-2-(substituted) pyrroles and their use for the treatment of neurodegenerative dysfunctions |
| 02/09/1994 | EP0582169A2 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| 02/09/1994 | EP0582164A1 Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
| 02/09/1994 | EP0582147A2 Anti-urease cosmetic or dermatologic composition |
| 02/09/1994 | EP0582146A2 Process for the preparation of imidazopyridines |
| 02/09/1994 | EP0582143A1 Methods for detecting Alzheimer's disease |
| 02/09/1994 | EP0582055A1 Perfluorocarbons as tamponade for the vitreous body cavity of the eye |
| 02/09/1994 | EP0581979A1 Quinic acid derivatives and process to prepare quinic acid derivatives |
| 02/09/1994 | EP0581959A1 Use of macrolide compounds for eye diseases |
| 02/09/1994 | EP0581955A1 Use of benzimidazole derivatives as protective light filters. |
| 02/09/1994 | EP0581954A1 USE OF -g(a)-HYDROXYKETOALKYL DERIVATIVES AS PROTECTIVE LIGHT FILTERS. |
| 02/09/1994 | EP0581939A1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors |
| 02/09/1994 | EP0581923A1 Phosphono derivatives of amino acids as metalloproteinase inhibitors |
| 02/09/1994 | EP0581916A1 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
| 02/09/1994 | EP0581907A1 Inhibitors of kynureninase |
| 02/09/1994 | EP0581906A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs |
| 02/09/1994 | EP0581899A1 Improved process for the preparation of 1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n- (1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide |
| 02/09/1994 | EP0581883A1 Blood substitutes and organ preservative solutions |
| 02/09/1994 | EP0581865A1 Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins |
| 02/09/1994 | EP0581856A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 02/09/1994 | EP0581849A1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 02/09/1994 | EP0581848A1 Closed sense and antisense oligonucleotides and uses thereof |
| 02/09/1994 | EP0581846A1 Sulfate polysaccharides, preparation method, pharmaceutical composition and utilization |
| 02/09/1994 | EP0581844A1 Process for producing pvp-h 2?o 2? products. |
| 02/09/1994 | EP0581805A1 Novel pyridazines |
| 02/09/1994 | EP0581803A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 02/09/1994 | EP0581797A1 Novel thiophene-2-carboxylic acid derivatives and process for their production. |
| 02/09/1994 | EP0581789A1 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof |
| 02/09/1994 | EP0581777A1 Stereoselective preparation of substituted piperidines |
| 02/09/1994 | EP0497756B1 Antithrombotic composition |
| 02/09/1994 | CN1081688A 5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds |
| 02/09/1994 | CN1081682A 甾类衍生物 Steroid derivatives |
| 02/09/1994 | CN1081679A Derivatives of substituted imidazo benzoxazin-1-one and process for their preparation |
| 02/09/1994 | CN1081678A Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| 02/09/1994 | CN1081676A Indole and indazole derivatives for the treatment and prophylaxis of cerebral disorders, their preparation and their use |
| 02/09/1994 | CN1081671A The use of old drugs for the treatment of diabetes |
| 02/09/1994 | CN1081669A Compounds for the treatment of nemodegenerative disorders |
| 02/09/1994 | CN1081614A Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 02/09/1994 | CN1023702C Process for preparing imidazole derivative |
| 02/09/1994 | CN1023700C Aromatic and heterocyclic carboxamide derivatives as antineoplastic agent and preparation method thereof |
| 02/09/1994 | CA2141030A1 Liponucleotides of seco-nucleosides, their production as well as their use as antiviral pharmaceutical agents |
| 02/08/1994 | US5284967 For treating swine |
| 02/08/1994 | US5284963 Reacting 9-amino tetracycline derivative with haloacyl halide in mixture of polar aprotic solvent, inert solvent, base; reacting product under inert atmosphere with nucleophilic amine |
| 02/08/1994 | US5284957 Substituted 1H- or 2H-tetrazoles |
| 02/08/1994 | US5284941 Process for obtaining glycolipids and phospholipids |
| 02/08/1994 | US5284876 Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents |
| 02/08/1994 | US5284875 Fortified quarternary ammonium compound with dual synergistic phenols |
| 02/08/1994 | US5284874 Administering pantetheine |
| 02/08/1994 | US5284873 Treatment of benign hypertrophy of the prostate |
| 02/08/1994 | US5284870 Aldose reductase inhibitor |